6Chevalier TL, Brisgand D, Douillard JY, et al. Randomized study of vinorelbin e and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advan ced non-small cell lung cancer:results of a European multicenter trail including 612 patients. J Clin Oncology, 1994,12(2):360-367.
7Antoinette JW, Growley JJ, Balcerzak SP, et al. Randomized trail comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small cell lung cancer: A southwest oncology group study. J Clin Oncol, 1998,16:2459.
1Levi F, Misset JL, Brienza S, et al. A chronopharmacologic phase Ⅱ clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump[J]. Cancer,1992,69:893 - 900.
2Group, N-sclc. Chemotherapy in non-small-cell lung cancer: metaanalysis using updated data on individual patients from 52 randomized clinical trials[J]. Br Med J, 1995,311:899.
3Rapp E, Pater J, Willan A, et al. Chemotherapy can prolong survial in patients with advanced non-small-cell lung cancer - report of a Canadian multicenter randomized trial[J]. J Clin Oncol,1988,6:633.
4Clinical practice gurdelines for the treament of unresectable nonsmall-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology [J]. J Clin Oncol, 1997, 15 (8):2996.
5Monnet I, Brienza S, Hugret F, et al. Phase Ⅱ study of oxaliplatin in poor-prognosis non-small-cell lung cancer(NSCLC). ATTT.Association Pour le Treatment des Tumours Intre Thoraciques[J].Eur J Cancer, 1998 Jun ,34 (7): 1124 - 1127.
6I. Monnet, H. de Cemou, P. Soulie, et al. Oxaliplatin plus vinorelbine in advanced non-small-cell lung cancer:final results of a multicenter phase Ⅱ study[J]. Ann Oncol, 2002 Jan, 13(1):103-107.
